Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FOLH1 (clone h1G0ZB3). We employs the pAS (CMV-RFP-IL-4-HindIII) vector components and the SynExpress system of the Single base pair Deletion/Negative feedback for a robust and sustained response against cancers.
Host
humanized
Target
FOLH1
Clone
h1G0ZB3
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
Deletion
Modification Domain
Single base pair
Carrier Type
pAS
Transformation Accuracy
0.99
Cell Culture
3D Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.